We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advisors Recommend Teva’s Asthma Drug, But Not for Adolescents
FDA Advisors Recommend Teva’s Asthma Drug, But Not for Adolescents
With such a strong unmet need in severe asthma patients and convincing evidence of improvement in this population, Teva Pharmaceuticals’ candidate reslizumab warrants approval, FDA advisors said Wednesday.